Search

Your search keyword '"Vincent J Pompili"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Vincent J Pompili" Remove constraint Author: "Vincent J Pompili"
86 results on '"Vincent J Pompili"'

Search Results

1. Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia

2. Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities.

Catalog

Books, media, physical & digital resources

3. Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model.

4. Nanofiber-expanded human CD34+ cells heal cutaneous wounds in streptozotocin-induced diabetic mice

5. Myeloid Krüppel-Like Factor 2 Critically Regulates K/BxN Serum-Induced Arthritis

6. Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis

7. Corrigendum to 'Retention of stemness and vasculogenic potential of human umbilical cord blood stem cells after repeated expansions on PES-nanofiber matrices' [Biomaterials 35 (2014) 8566–8575]

8. Nanofiber-expanded human CD34

9. Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease

10. Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions

11. Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10

12. Nanofiber-expanded human umbilical cord blood–derived CD34+ cell therapy accelerates cutaneous wound closure in NOD/SCID mice

13. Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors

14. Transgenic swine: Expression of human CD39 protects against myocardial injury

15. Kruppel-Like Factor 2 (KLF2) Regulates Monocyte Differentiation and Functions in mBSA and IL-1β-Induced Arthritis

16. Neovascularization and Hematopoietic Stem Cells

17. Plasticity and Maintenance of Hematopoietic Stem Cells During Development

18. Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia

19. Umbilical cord blood-selected CD133+ cells exhibit vasculogenic functionality in vitro and in vivo

20. Ex Vivo Nanofiber Expansion and Genetic Modification of Human Cord Blood-Derived Progenitor/Stem Cells Enhances Vasculogenesis

21. Transvenous Intramyocardial Cellular Delivery Increases Retention in Comparison to Intracoronary Delivery in a Porcine Model of Acute Myocardial Infarction

22. Umbilical cord blood stem cells: Implications for cardiovascular regenerative medicine

23. Direct Comparison of Umbilical Cord Blood versus Bone Marrow–Derived Endothelial Precursor Cells in Mediating Neovascularization in Response to Vascular Ischemia

24. Generation of osteoporosis in immune-compromised mice for stem cell therapy

25. Retention of stemness and vasculogenic potential of human umbilical cord blood stem cells after repeated expansions on PES-nanofiber matrices

26. Duration of intra-aortic balloon pump use and related complications

27. Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions

28. Coronary Angioplasty and Stenting in Orthotopic Heart Transplants: A Fruitful Act or a Futile Attempt?

29. Stem cell therapy: A 'magic bullet' for cardiomyopathies?*

30. TCT-561 Final Five-Year Outcomes Following Implantation of the Promus Element® Platinum Chromium Everolimus-Eluting Stent in De Novo Coronary Artery Lesions in Small Vessels (SV) and Long Lesions (LL): Results of the PLATINUM Small Vessel and Long Lesion Trials

31. Enhanced Angiogenesis and Unfavorable Remodeling in Injured Porcine Coronary Artery Lesions: Effects of Local Basic Fibroblast Growth Factor Delivery

32. Expression and Function of Recombinant Endothelial Nitric Oxide Synthase Gene in Canine Basilar Artery

33. Hematopoietic Stem Cells and Bone Regeneration

34. THREE–YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE v EVEROLIMUS–ELUTING STENTS

35. Vascular Stem Cells in Regulation of Angiogenesis

36. Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: vascular complications and incidence of bleeding

37. Catheter-mediated pulmonary vascular gene transfer and expression

38. Gene transfer and vascular disease

39. Ischemia, Reactive Radicals, Redox Signaling and Hematopoietic Stem Cells

40. Ex Vivo Expanded Hematopoietic Stem Cells for Ischemia

41. Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application

42. Third degree AV block due to ophthalmic timolol solution

43. Fibroelastoma presenting as an ST-segment elevation myocardial infarction with distal embolization of the left coronary circulation

44. A novel technology for hematopoietic stem cell expansion using combination of nanofiber and growth factors

45. Abstract 1144: Successful Surface-Aminated Nanofiber Expansion of Human Umbilical Cord-Derived CD133+ Cells Leads to Augmentation of Angiogenic Functionality In Vitro and In Vivo

46. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia

48. Recombinant Gene Transfer of Endothelial Nitric Oxide Synthase Augments Coronary Artery Relaxations During Hypoxia

49. Saphenous vein graft ectasia: an unusual late complication of coronary artery bypass surgery. A case report

50. 253: Diminished Biological Potency of BM-Derived CD133+ Cells Obtained from Patients with Coronary Artery Disease in in vitro and in vivo Studies